Growing Role for Androgen-Targeting Therapies in CRPC

Growing Role for Androgen-Targeting Therapies in CRPC
A second phase III trial in the prechemotherapy setting demonstrated that men treated with abiraterone achieved a significant increase in radiographic progression-free survival (rPSF) but the study did not show a statistically significant survival …
Read more on OncLive

Five easy steps build strong bones all year long
That's right guys, don't underestimate your odds of developing osteoporosis, especially if you have clinically low testosterone levels or you get hormone therapy for advanced prostate cancer. Too few men get the checkups and bone-saving treatments they …
Read more on Ocala